Ann: Half Year FY20 results Conference call, page-34

Integra is in the process of getting the holders used to the idea of this revenue stream being removed across the business. Read the open and transparent report which points very clearly to this.

They have other areas they will want to focus on, no point trying to compete in areas in which they are using old tech with high costs versus a nimble player on the rise with multiple platforms.

Some of our Aussie life sciences stocks may come under some acquisition pressure if this downturn continues........

You can pick any of them up for a 20+% discount at the moment.........